BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Transition products commencing 1 May 2024
Offer reference number: CM/TNS/05/2024
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin
Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)
Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)
Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)
CM/TNS/05/2024/02 - Apixaban, Sapropterin
Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)
Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Additional information:
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: …@atamis.co.uk
No supplier information available.